Kedar Purushottam Phadke
Geen lopende functies
Profiel
Kedar Purushottam Phadke worked as a Secretary at Kirloskar Pneumatic Co. Ltd.
in 2009 and as a Secretary & Compliance Officer at Emcure Pharmaceuticals Ltd.
from 2010 to 2014.
He also worked as a Secretary & Compliance Officer at Thermax Ltd.
from 2017 to 2021.
Eerdere bekende functies van Kedar Purushottam Phadke
| Bedrijven | Functie | Einde |
|---|---|---|
| THERMAX LIMITED | Compliance Officer | 19-08-2021 |
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Bedrijfssecretaris | - |
| KIRLOSKAR PNEUMATIC COMPANY LIMITED | Algemeen Adviseur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| KIRLOSKAR PNEUMATIC COMPANY LIMITED | Producer Manufacturing |
| THERMAX LIMITED | Producer Manufacturing |
| Bedrijven in privébezit | 1 |
|---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
